These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36791209)

  • 1. IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases.
    Lavazais S; Jargosch M; Dupont S; Labéguère F; Menet C; Jagerschmidt C; Ohm F; Kupcsik L; Parent I; Cottereaux C; Marsais F; Oste L; Van de Water A; Christophe T; De Vos S; Fallon P; Lauffer F; Clément-Lacroix P; Eyerich K; Brys R
    Sci Transl Med; 2023 Feb; 15(683):eabj3289. PubMed ID: 36791209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner.
    Cushing L; Stochaj W; Siegel M; Czerwinski R; Dower K; Wright Q; Hirschfield M; Casanova JL; Picard C; Puel A; Lin LL; Rao VR
    J Biol Chem; 2014 Apr; 289(15):10865-10875. PubMed ID: 24567333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRAK4 in TLR/IL-1R signaling: possible clinical applications.
    Li X
    Eur J Immunol; 2008 Mar; 38(3):614-8. PubMed ID: 18286571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of IRAK4 kinase activity improves ethanol-induced liver injury in mice.
    Wang H; Zhou H; Zhang Q; Poulsen KL; Taylor V; McMullen MR; Czarnecki D; Dasarathy D; Yu M; Liao Y; Allende DS; Chen X; Hong L; Zhao J; Yang J; Nagy LE; Li X
    J Hepatol; 2020 Dec; 73(6):1470-1481. PubMed ID: 32682051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 receptor-associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll-like receptors 4 and 7/8 in murine and human lungs.
    Sayers I; Thakker D; Billington C; Kreideweiss S; Grundl MA; Bouyssou T; Thamm S; Kreuz S; Hall IP
    Br J Pharmacol; 2024 Nov; 181(22):4647-4657. PubMed ID: 39137914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells.
    Corzo CA; Varfolomeev E; Setiadi AF; Francis R; Klabunde S; Senger K; Sujatha-Bhaskar S; Drobnick J; Do S; Suto E; Huang Z; Eastham-Anderson J; Katewa A; Pang J; Domeyer M; Dela Cruz C; Paler-Martinez A; Lau VWC; Hadadianpour A; Ramirez-Carrozi V; Sun Y; Bao K; Xu D; Hunley E; Brightbill HD; Warming S; Roose-Girma M; Wong A; Tam L; Emson CL; Crawford JJ; Young WB; Pappu R; McKenzie BS; Asghari V; Vucic D; Hackney JA; Austin CD; Lee WP; Lekkerkerker A; Ghilardi N; Bryan MC; Kiefer JR; Townsend MJ; Zarrin AA
    Sci Signal; 2020 Jun; 13(634):. PubMed ID: 32487715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
    Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.
    Kim TW; Staschke K; Bulek K; Yao J; Peters K; Oh KH; Vandenburg Y; Xiao H; Qian W; Hamilton T; Min B; Sen G; Gilmour R; Li X
    J Exp Med; 2007 May; 204(5):1025-36. PubMed ID: 17470642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
    Sun L; Liu W; Zhang LJ
    J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.
    Cushing L; Winkler A; Jelinsky SA; Lee K; Korver W; Hawtin R; Rao VR; Fleming M; Lin LL
    J Biol Chem; 2017 Nov; 292(45):18689-18698. PubMed ID: 28924041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A noncanonical IRAK4-IRAK1 pathway counters DNA damage-induced apoptosis independently of TLR/IL-1R signaling.
    Li Y; Shah RB; Sarti S; Belcher AL; Lee BJ; Gorbatenko A; Nemati F; Yu H; Stanley Z; Rahman M; Shao Z; Silva JM; Zha S; Sidi S
    Sci Signal; 2023 Dec; 16(816):eadh3449. PubMed ID: 38113335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
    Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
    J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling.
    De Nardo D; Balka KR; Cardona Gloria Y; Rao VR; Latz E; Masters SL
    J Biol Chem; 2018 Sep; 293(39):15195-15207. PubMed ID: 30076215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling.
    De S; Karim F; Kiessu E; Cushing L; Lin LL; Ghandil P; Hoarau C; Casanova JL; Puel A; Rao VR
    J Biol Chem; 2018 Sep; 293(39):15208-15220. PubMed ID: 30115681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease.
    Staschke KA; Dong S; Saha J; Zhao J; Brooks NA; Hepburn DL; Xia J; Gulen MF; Kang Z; Altuntas CZ; Tuohy VK; Gilmour R; Li X; Na S
    J Immunol; 2009 Jul; 183(1):568-77. PubMed ID: 19542468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3, 3'- diindolylmethane hinders IL-17A/IL-17RA interaction and mitigates imiquimod-induced psoriasiform in mice.
    Srikanth M; Rasool M
    Int Immunopharmacol; 2022 Aug; 109():108795. PubMed ID: 35487087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor signalling via IRAK4 affects epithelial integrity and tightness through regulation of junctional tension.
    Peterson J; Balogh Sivars K; Bianco A; Röper K
    Development; 2023 Dec; 150(24):. PubMed ID: 37997696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor-associated kinase 4 (IRAK4).
    Wang L; Ferrao R; Li Q; Hatcher JM; Choi HG; Buhrlage SJ; Gray NS; Wu H
    J Biol Chem; 2019 Mar; 294(12):4511-4519. PubMed ID: 30679311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.
    Murphy M; Pattabiraman G; Manavalan TT; Medvedev AE
    Eur J Immunol; 2017 May; 47(5):880-891. PubMed ID: 28295231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.